Advertisement

Fully vaccinated people can skip 14-day quarantine after exposure, U.S. CDC says

Click to play video 'U.S. COVID-19 cases, hospitalizations appear to show ‘consistent downward trajectory,’ CDC head says' U.S. COVID-19 cases, hospitalizations appear to show ‘consistent downward trajectory,’ CDC head says
WATCH: U.S. COVID-19 cases, hospitalizations appear to show ‘consistent downward trajectory,’ CDC head says – Feb 3, 2021

People who have received the full course of COVID-19 vaccines can skip the standard 14-day quarantine after exposure to someone with the infection as long as they remain asymptomatic, U.S. public health officials advised.

The U.S. Centers for Disease Control and Prevention (CDC) said on Wednesday the vaccines have been shown to prevent symptomatic COVID-19, thought to play a greater role in the transmission of the virus than asymptomatic disease.

“Individual and societal benefits of avoiding unnecessary quarantine may outweigh the potential but unknown risk of transmission (among vaccinated individuals),” the CDC said.

Read more: Wearing a mask also helps protect you from coronavirus, CDC says

The agency has laid down a strict criteria for people who would no longer have to quarantine after the vaccinations, including those who have received both the doses of a two-dose vaccine.

Story continues below advertisement

People who choose not to quarantine should do so only if they received their last dose within three months, and should only avoid 14 days quarantine after their last shot, the time it takes to develop immunity, CDC said.

Click to play video 'Coronavirus: CDC reports nearly 700 cases of COVID-19 variants across 34 states' Coronavirus: CDC reports nearly 700 cases of COVID-19 variants across 34 states
Coronavirus: CDC reports nearly 700 cases of COVID-19 variants across 34 states – Feb 8, 2021

Fully vaccinated persons who do not quarantine should still watch for symptoms for 14 days following an exposure.

Two-dose vaccines from Pfizer Inc and Moderna Inc have been authorized for emergency use in the United States. Johnson & Johnson applied for a U.S. authorization of its single-dose shot last week.

As of Wednesday, 44,769,970 doses of COVID-19 vaccines in the country had been administered and 65,972,575 doses had been delivered.

(Reporting by Manas Mishra and Rama Venkat in Bengaluru; Editing by Shounak Dasgupta and Sriraj Kalluvila)

Advertisement